BIOCRYST PHARMACEUTICALS INC BCRX

US Healthcare Biological Products, (No Diagnostic Substances)
$9.84
+2.0%
52w: $6.24 – $10.10

Latest 13F among current holders filed 11 days ago (Jun 24, 2026)

Price — last 12 months

research preview data
6.248.1710.10
Jun 20, 2025 Jul 2, 2026
Institutional holders
301
+27 QoQ
13F value
$2.37B
+43.0% QoQ
Smart-money holders
22
signal tier ≥ 2
New smart buyers
8
Q1 2026
Options barometer
2.3×
$14.2M calls / $6.1M puts

Institutional value by quarter

$965.9M
Q1 2024
$1.08B
Q2 2024
$1.32B
Q3 2024
$1.26B
Q4 2024
$1.32B
Q1 2025
$1.77B
Q2 2025
$1.48B
Q3 2025
$1.66B
Q4 2025
$2.37B
Q1 2026

Number of holders

238
Q1 2024
242
Q2 2024
258
Q3 2024
259
Q4 2024
276
Q1 2025
295
Q2 2025
286
Q3 2025
274
Q4 2025
301
Q1 2026

Who owns BCRX?

Q1 2026 filings
FundTypeSharesValue% of fundChange
BlackRock, Inc. Index provider22.7M$215.6M0.0%+7.2%
RA CAPITAL MANAGEMENT, L.P. ★2Fundamental diversified15.8M$150.7M1.6%Held
DEERFIELD MANAGEMENT COMPANY, L.P. Quant stat arb15.0M$143.2M2.0%+4.9%
STATE STREET CORP Index provider12.2M$116.2M0.0%+10.3%
VANGUARD PORTFOLIO MANAGEMENT LLC Diversified mechanical11.2M$107.0M0.0%
VANGUARD CAPITAL MANAGEMENT LLC Diversified mechanical11.1M$106.0M0.0%
TCG Crossover Management, LLC ★3Fundamental concentrated11.0M$104.9M3.0%New
JANUS HENDERSON GROUP PLC Diversified mechanical8.9M$84.9M0.0%+20.3%
PERCEPTIVE ADVISORS LLC ★2Fundamental diversified7.4M$70.8M1.4%+135.1%
Vestal Point Capital, LP ★2Fundamental diversified7.0M$66.9M1.9%+212.2%
TWO SIGMA INVESTMENTS, LP Quant stat arb6.4M$60.9M0.1%+41.6%
GEODE CAPITAL MANAGEMENT, LLC Index provider5.8M$55.1M0.0%+14.4%
Kynam Capital Management, LP ★3Fundamental concentrated5.7M$54.1M3.4%-39.4%
BANK OF AMERICA CORP /DE/ Bank broker5.1M$48.5M0.0%+231.6%
Aberdeen Group plc Other5.0M$48.0M0.1%+451.7%
UBS Group AG Bank broker4.9M$47.1M0.0%-6.1%
Frazier Life Sciences Management, L.P. ★3Fundamental concentrated4.0M$38.2M1.0%New
Royalty Pharma Sub-Manager, LLC ★2Fundamental diversified3.8M$36.6M21.2%Held
Nuveen, LLC Diversified mechanical3.8M$36.4M0.0%+5.7%
GW&K Investment Management, LLC Other3.2M$30.9M0.3%+2.5%
Eversept Partners, LP ★2Fundamental diversified3.0M$28.9M1.9%+1.6%
RFG Advisory, LLC Wealth advisor2.9M$27.3M0.5%New
SUSQUEHANNA INTERNATIONAL GROUP, LLP Market maker2.8M$26.8M0.0%+319.1%
Fisher Asset Management, LLC Long only active2.7M$26.0M0.0%+10.8%
DIMENSIONAL FUND ADVISORS LP Quant stat arb2.7M$25.6M0.0%+119.0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC Index provider2.4M$22.4M0.0%+17.2%
GOLDMAN SACHS GROUP INC Bank broker2.3M$22.3M0.0%-26.9%
Candriam S.C.A. Other2.3M$21.8M0.1%New
RICE HALL JAMES & ASSOCIATES, LLC Other2.2M$21.2M1.2%+17.1%
NORTHERN TRUST CORP Index provider2.1M$20.0M0.0%+13.3%
MORGAN STANLEY Bank broker2.0M$19.3M0.0%+15.9%
Nantahala Capital Management, LLC ★2Fundamental diversified2.0M$18.9M1.2%+46.5%
STIFEL FINANCIAL CORP Diversified mechanical1.8M$17.4M0.0%0.0%
Parkman Healthcare Partners LLC Other1.7M$16.3M1.7%+89.8%
VANGUARD FIDUCIARY TRUST CO Diversified mechanical1.7M$15.8M0.0%
Pacer Advisors, Inc. Diversified mechanical1.6M$14.9M0.0%New
JPMORGAN CHASE & CO Bank broker1.5M$14.6M0.0%+82.8%
ORBIMED ADVISORS LLC ★2Fundamental diversified1.4M$13.6M0.3%-18.2%
Legal & General Group Plc Diversified mechanical1.4M$13.4M0.0%+568.8%
Schonfeld Strategic Advisors LLC Multistrat pod1.3M$12.7M0.1%+845.7%
Invesco Ltd. Index provider1.3M$12.5M0.0%-3.4%
BNP PARIBAS FINANCIAL MARKETS Bank broker1.3M$12.4M0.0%-48.8%
Man Group plc Quant stat arb1.3M$12.3M0.0%+217.1%
OP Asset Management Ltd Other1.3M$11.9M0.1%+800.0%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND Diversified mechanical1.2M$11.7M0.0%New
JUPITER ASSET MANAGEMENT LTD Other1.2M$11.4M0.1%-0.1%
CITADEL ADVISORS LLC Multistrat pod1.0M$9.7M0.0%-21.6%
JACOBS LEVY EQUITY MANAGEMENT, INC Other1.0M$9.6M0.0%-2.6%
Elmind Capital, LP ★3Fundamental concentrated1.0M$9.5M2.7%-53.5%
Rosalind Advisors, Inc. ★2Fundamental concentrated923.1K$8.8M3.6%New

Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.